Variable | Total patients | High Gal3 | Low Gal3 |
---|---|---|---|
Age |  | p = 0.41 |  |
 20–35 yr | 7 | 2 | 5 |
 36–50 yr | 48 | 12 | 36 |
 51–70 yr | 31 | 9 | 22 |
  > 70 yr | 1 | 0 | 1 |
Race |  | p = 0.25 |  |
 Black | 7 | 3 | 4 |
 White | 61 | 18 | 43 |
 Hispanic | 14 | 2 | 12 |
 Other | 5 | 0 | 5 |
Menopausal status |  | p = 0.57 |  |
 Pre | 47 | 13 | 34 |
 Post | 37 | 10 | 27 |
 Unknown | 3 | 0 | 3 |
pT stage |  | p = 0.22 |  |
 pT1 (0–2 cm) | 22 | 9 | 13 |
 pT2 (2–5 cm) | 55 | 13 | 42 |
 pT3 (>5 cm) | 7 | 1 | 6 |
 Unknown | 3 | 0 | 3 |
Tumor grade |  | p = 0.41 |  |
 1 | 5 | 2 | 3 |
 2 | 38 | 12 | 26 |
 3 | 44 | 9 | 35 |
pN stage |  | p = 0.36 |  |
 N1 (1–3 LN) | 60 | 16 | 44 |
 N2 (4–9 LN) | 19 | 5 | 14 |
 N3 (>9 LN) | 8 | 2 | 6 |
Lymphovascular invasion |  | p = 0.01 |  |
 Present | 38 | 5 | 33 |
 Absent | 49 | 18 | 31 |
ER |  | p = 0.56 |  |
 Positive | 53 | 13 | 40 |
 Negative | 33 | 10 | 23 |
 Unknown | 1 | 0 | 1 |
PR |  | p = 0.37 |  |
 Positive | 40 | 9 | 31 |
 Negative | 45 | 14 | 31 |
 Unknown | 2 | 0 | 2 |
HER2 |  | p = 0.21 |  |
 0 | 48 | 13 | 35 |
 1+ | 13 | 2 | 11 |
 2+ | 5 | 0 | 5 |
 3+ | 20 | 8 | 12 |
 Unknown | 1 | 0 | 1 |